CVI Holdings’s Phio Pharmaceuticals PHIO Stock Holding History

CVI Holdings’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,334	Closed	-$637K	–	73
2020 Q1	$637K	Buy	+3,334	New	+$2.05M	2.24%	10
2019 Q4	–	Sell	-16	Closed	-$26K	–	43
2019 Q3	$26K	Sell	16 -52	-76%	-$109K	0.06%	30
2019 Q2	$154K	Sell	68 -34	-33%	-$89.2K	0.18%	38
2019 Q1	$272K	Buy	102 +76	+292%	+$170K	0.26%	29
2018 Q4	$51K	Buy	+26	New	+$61.4K	0.11%	22

Other funds holding PHIO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

CVI Holdings's PHIO Position: Q2 2020 in Review

CVI Holdings sold out of Phio Pharmaceuticals (PHIO) in Q2 2020, closing a stake of 3,334 shares — an estimated $637K sold.

CVI Holdings first reported a position in PHIO in Q4 2018 and held it in 5 quarters. The position peaked at $637K in Q1 2020. 6 funds tracked by Wall St. Rank hold PHIO as of Q2 2020.

CVI Holdings reported no remaining Phio Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
CVI Holdings sold 3,334 Phio Pharmaceuticals shares in Q2 2020, an estimated $637K.
CVI Holdings first reported a position in Phio Pharmaceuticals in Q4 2018 and held it in 5 quarters.
CVI Holdings's Phio Pharmaceuticals position peaked at $637K in Q1 2020.
6 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2020.

Based on CVI Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.